CAS: 75425-27-3 - 8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)-4H,8H-pyrano[2,3-f]chromen-4-one
Formula:C23H22O6
InChI:InChI=1S/C23H22O6/c1-23(2)9-8-13-17(29-23)7-6-14-21(24)16(12-28-22(13)14)15-10-19(26-4)20(27-5)11-18(15)25-3/h6-12H,1-5H3
InChI key:InChIKey=OBIUGMGQVQMVSK-UHFFFAOYSA-N
SMILES:O=C1C(=COC2=C3C=CC(OC3=CC=C12)(C)C)C=4C=C(OC)C(OC)=CC4OC
- Synonyms:
- 4H,8H-Benzo(1,2-b:3,4-b')dipyran-4-one, 8,8-dimethyl-3-(2,4,5-trimethoxyphenyl)-
- 8,8-Dimethyl-3-(2,4,5-trimethoxyphenyl)-4H,8H-benzo[1,2-b:3,4-b′]dipyran-4-one
- Barbigerone
- Ionchocarpusone
- Lonchocarpusone
Brand | Product data | Purity | Price range | Estimated delivery |
---|---|---|---|---|
Barbigerone-d3 REF: TR-B118302CAS: 75425-27-3 | - - - | 9,045.00 € | Mon 27 Jan 25 | |
Barbigerone REF: TR-B118300CAS: 75425-27-3 | - - - | 3,578.00 € | Mon 27 Jan 25 | |
Barbigerone REF: 3D-ADA42527CAS: 75425-27-3 | Min. 95% | To inquire | Tue 28 Jan 25 | |
Barbigerone REF: TM-T23773CAS: 75425-27-3 | 98% | 904.00 €~2,329.00 € | Tue 04 Feb 25 |
Barbigerone-d3
Controlled ProductCAS:75425-27-3
Formula:
C23D3H19O6
Color and Shape:
Neat
Molecular weight:
397.436
Ref: TR-B118302
250mg | 9,045.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Barbigerone
Controlled ProductCAS:75425-27-3
Formula:
C23H22O6
Color and Shape:
Neat
Molecular weight:
394.417
Ref: TR-B118300
250mg | 3,578.00 € |
Estimated delivery in United States, on Monday 27 Jan 2025
Barbigerone
CAS:75425-27-3
Barbigerone is a carotenoid that has anti-angiogenic effects. It inhibits the growth of blood vessels …
Formula:
C23H22O6
Purity:
Min. 95%
Molecular weight:
394.4 g/mol
Ref: 3D-ADA42527
50mg | To inquire | ||
100mg | To inquire |
Estimated delivery in United States, on Tuesday 28 Jan 2025
Barbigerone
CAS:75425-27-3
Barbigerone is a tumor angiogenesis, growth, and metastasis inhibitor in melanoma.
Formula:
C23H22O6
Purity:
98%
Color and Shape:
Solid
Molecular weight:
394.42
Ref: TM-T23773
25mg | 1,410.00 € | ||
50mg | 1,845.00 € | ||
100mg | 2,329.00 € |
Estimated delivery in United States, on Tuesday 4 Feb 2025